2016
DOI: 10.6002/ect.tondtdtd2016.p66
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Objectives: Weight gain and obesity are frequent problems for renal transplant patients. The purpose of this review is to show why weight gain is experienced by patients after kidney transplant and the significance of prevention. Materials and Methods: To investigate this topic, PubMed and Ulakbim databases were searched with the following key words: renal transplant and transplantation, weight gain, and obesity. Results: Weight gain frequently appears in the first year after transplant, and it is reported to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…There is evidence that KTx recipients are susceptible to weight gain after transplantation (16,17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m 2 ) were 14.8% (before KTx) and 19.9% (after KTx), respectively.…”
Section: Introductionmentioning
confidence: 99%
“…There is evidence that KTx recipients are susceptible to weight gain after transplantation (16,17). In a large German sample of patients before and after kidney transplantation (n = 433), the frequencies of obesity (BMI > 30 kg/m 2 ) were 14.8% (before KTx) and 19.9% (after KTx), respectively.…”
Section: Introductionmentioning
confidence: 99%
“…There is a positive association with an increase in adipose tissue (visceral and sub-cutaneous) with insulin resistance in KTRs ( 5 ). Factors underlying post kidney transplant weight gain include reduced physical function ( 6 ) and physical activity (PA) ( 7 ), increased appetite, ( 3 ) steroid medication use ( 8 ), and the lifting of dietary restrictions ( 9 ). Whilst “triple therapy” anti-rejection regimes including steroid medication are current practice to reduce the risk of graft failure ( 10 12 ), they have been found to increase both the severity and incidence of cardiovascular risk factors ( 13 ).…”
Section: Introductionmentioning
confidence: 99%